ervous system complications in HIV infectio
Phase 1
- Conditions
- Health Condition 1: B20- Human immunodeficiency virus [HIV]disease
- Registration Number
- CTRI/2023/04/051412
- Lead Sponsor
- Department of General Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
PLWH patients diagnosed as per NACO guidelines, presenting with neurological
manifestations of HIV
Age greater than or equal to 18
Exclusion Criteria
Patients with Traumatic brain injury
Patients with any other comorbidities/diseases causing neurological manifestationsvunrelated to HIV
Patient not providing consent.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To document the neurological complications in HIV infection in terms of clinical, laboratory and radiological findingsTimepoint: At the end of study period
- Secondary Outcome Measures
Name Time Method To study the occurrence of neurological complications in patients on HAART. <br/ ><br>To compare the occurrence of neurological complications in drug naïve patients vs <br/ ><br>patients on HAART. <br/ ><br>To compare the clinico-radiological profile of CNS toxoplasmosis and CNS tuberculosisTimepoint: At the end of study